Skip to main content
. 2016 Nov 4;7(50):83437–83450. doi: 10.18632/oncotarget.13118

Table 3. heterogeneity test analysis -(GT)n repeat length polymorphism with CHD.

Study Heterogeneity test
H I2 P
Allele model(S/L) 1.21 31.40% 0.132
Recessive model(SS/SL+LL) 1.27 38.30% 0.078
Dominant model(SS+SL/LL) 1.07 12.40% 0.320
Co-dominant model(SL/LL) 1.01 2.70% 0.420
Co-dominant model(SS/LL) 1.25 35.90% 0.096